Charles L. Sawyers Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center Biography Publications Institution JoVE Articles Charles L. Sawyers has not added a biography. If you are Charles L. Sawyers and would like to personalize this page please email our Author Liaison for assistance. Publications A Rectal Cancer Organoid Platform to Study Individual Responses to Chemoradiation Nature Medicine. Oct, 2019 | Pubmed ID: 31591597 Herceptin: A First Assault on Oncogenes That Launched a Revolution Cell. Sep, 2019 | Pubmed ID: 31519311 FOXA1 Mutations Alter Pioneering Activity, Differentiation and Prostate Cancer Phenotypes Nature. 07, 2019 | Pubmed ID: 31243370 Publisher Correction: The Long Tail of Oncogenic Drivers in Prostate Cancer Nature Genetics. Jul, 2019 | Pubmed ID: 31152158 Genomic Correlates of Clinical Outcome in Advanced Prostate Cancer Proceedings of the National Academy of Sciences of the United States of America. Jun, 2019 | Pubmed ID: 31061129 Amplifies Androgen Receptor Output in Human Prostate Cancer and Contributes to Antiandrogen Resistance ELife. Jan, 2019 | Pubmed ID: 30644358 Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade JAMA Oncology. Apr, 2019 | Pubmed ID: 30589920 SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2019 | Pubmed ID: 30587545 Strategies to Identify and Target Cells of Origin in Prostate Cancer Journal of the National Cancer Institute. Mar, 2019 | Pubmed ID: 30312421 American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives JCO Clinical Cancer Informatics. 12, 2018 | Pubmed ID: 30652542 Immunogenomic Analyses Associate Immunological Alterations with Mismatch Repair Defects in Prostate Cancer The Journal of Clinical Investigation. 10, 2018 | Pubmed ID: 30179225 Tumor Copy Number Alteration Burden is a Pan-cancer Prognostic Factor Associated with Recurrence and Death ELife. 09, 2018 | Pubmed ID: 30178746 Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer Cellular and Molecular Gastroenterology and Hepatology. 2018 | Pubmed ID: 30109253 Patient Derived Organoids to Model Rare Prostate Cancer Phenotypes Nature Communications. 06, 2018 | Pubmed ID: 29921838 The Long Tail of Oncogenic Drivers in Prostate Cancer Nature Genetics. 05, 2018 | Pubmed ID: 29610475 Challenges in Validating Candidate Therapeutic Targets in Cancer ELife. 02, 2018 | Pubmed ID: 29417929 Targeting DNA Repair in Prostate Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 04, 2018 | Pubmed ID: 29369701 Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting European Urology. 05, 2018 | Pubmed ID: 29258679 Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity As a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer JAMA Oncology. Feb, 2018 | Pubmed ID: 29121144 Deletion of 3p13-14 Locus Spanning FOXP1 to SHQ1 Cooperates with PTEN Loss in Prostate Oncogenesis Nature Communications. 10, 2017 | Pubmed ID: 29057879 Regulation of the Glucocorticoid Receptor Via a BET-dependent Enhancer Drives Antiandrogen Resistance in Prostate Cancer ELife. 09, 2017 | Pubmed ID: 28891793 Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA Vs Guideline-Based Germline Testing JAMA. 09, 2017 | Pubmed ID: 28873162 Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making JCO Precision Oncology. Jul, 2017 | Pubmed ID: 28825054 ERF Mutations Reveal a Balance of ETS Factors Controlling Prostate Oncogenesis Nature. 06, 2017 | Pubmed ID: 28614298 Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions The New England Journal of Medicine. 05, 2017 | Pubmed ID: 28538124 SOX2 Promotes Lineage Plasticity and Antiandrogen Resistance in TP53- and RB1-deficient Prostate Cancer Science (New York, N.Y.). 01, 2017 | Pubmed ID: 28059768 Rb1 and Trp53 Cooperate to Suppress Prostate Cancer Lineage Plasticity, Metastasis, and Antiandrogen Resistance Science (New York, N.Y.). 01, 2017 | Pubmed ID: 28059767 Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells That Can Initiate Human Prostate Cancer and Predict Poor Outcome Cell Reports. 12, 2016 | Pubmed ID: 27926864 A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon PloS One. 2016 | Pubmed ID: 27536883 Facilitating a Culture of Responsible and Effective Sharing of Cancer Genome Data Nature Medicine. 05, 2016 | Pubmed ID: 27149219 Organoid Culture Systems for Prostate Epithelial and Cancer Tissue Nature Protocols. Feb, 2016 | Pubmed ID: 26797458 Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins Molecular Pharmaceutics. Feb, 2016 | Pubmed ID: 26725682 Identification of Different Classes of Luminal Progenitor Cells Within Prostate Tumors Cell Reports. Dec, 2015 | Pubmed ID: 26628377 Emerging Mechanisms of Resistance to Androgen Receptor Inhibitors in Prostate Cancer Nature Reviews. Cancer. Dec, 2015 | Pubmed ID: 26563462 All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care Through the Global Alliance for Genomics and Health Cancer Discovery. Nov, 2015 | Pubmed ID: 26526696 Androgen Receptor Upregulation Mediates Radioresistance After Ionizing Radiation Cancer Research. Nov, 2015 | Pubmed ID: 26432404 Identification of an Oncogenic RAB Protein Science (New York, N.Y.). Oct, 2015 | Pubmed ID: 26338797 Integrative Clinical Genomics of Advanced Prostate Cancer Cell. May, 2015 | Pubmed ID: 26000489 Feedback Suppression of PI3Kα Signaling in PTEN-mutated Tumors is Relieved by Selective Inhibition of PI3Kβ Cancer Cell. Jan, 2015 | Pubmed ID: 25544636 Identifying Actionable Targets Through Integrative Analyses of GEM Model and Human Prostate Cancer Genomic Profiling Molecular Cancer Therapeutics. Jan, 2015 | Pubmed ID: 25381262 MAGI-2 Scaffold Protein is Critical for Kidney Barrier Function Proceedings of the National Academy of Sciences of the United States of America. Oct, 2014 | Pubmed ID: 25271328 Cabozantinib Resolves Bone Scans in Tumor-naïve Mice Harboring Skeletal Injuries Molecular Imaging. 2014 | Pubmed ID: 25248353 Reliable and Effective Diagnostics Are Keys to Accelerating Personalized Cancer Medicine and Transforming Cancer Care: a Policy Statement from the American Association for Cancer Research Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2014 | Pubmed ID: 25204554 Organoid Cultures Derived from Patients with Advanced Prostate Cancer Cell. Sep, 2014 | Pubmed ID: 25201530 Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures Cell. Sep, 2014 | Pubmed ID: 25201529 CDK9-mediated Transcription Elongation is Required for MYC Addiction in Hepatocellular Carcinoma Genes & Development. Aug, 2014 | Pubmed ID: 25128497 Copy Number Alteration Burden Predicts Prostate Cancer Relapse Proceedings of the National Academy of Sciences of the United States of America. Jul, 2014 | Pubmed ID: 25024180 Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade Cell. Dec, 2013 | Pubmed ID: 24315100 "N of 1" Case Reports in the Era of Whole-genome Sequencing The Journal of Clinical Investigation. Nov, 2013 | Pubmed ID: 24135144 Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers Cancer Discovery. Nov, 2013 | Pubmed ID: 24027196 Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-resistant Prostate Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2013 | Pubmed ID: 24002508 ETS Factors Reprogram the Androgen Receptor Cistrome and Prime Prostate Tumorigenesis in Response to PTEN Loss Nature Medicine. Aug, 2013 | Pubmed ID: 23817021 Perspective: Combined Forces Nature. Jun, 2013 | Pubmed ID: 23803949 Developing Standards for Breakthrough Therapy Designation in Oncology Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2013 | Pubmed ID: 23719260 Overcoming Mutation-based Resistance to Antiandrogens with Rational Drug Design ELife. Apr, 2013 | Pubmed ID: 23580326 β4 Integrin Signaling Induces Expansion of Prostate Tumor Progenitors The Journal of Clinical Investigation. Feb, 2013 | Pubmed ID: 23348745 Fardeau De La Tumeur Dans Le Cerveau Avec 89Zr-transferrine De L'imagerie Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Jan, 2013 | Pubmed ID: 23236019 The 2011 Gordon Wilson Lecture: Overcoming Resistance to Targeted Cancer Drugs Transactions of the American Clinical and Climatological Association. 2012 | Pubmed ID: 23303979 Annotating MYC Status with 89Zr-transferrin Imaging Nature Medicine. Oct, 2012 | Pubmed ID: 23001181 Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors Cancer Research. Dec, 2012 | Pubmed ID: 22971343 JNK and PTEN Cooperatively Control the Development of Invasive Adenocarcinoma of the Prostate Proceedings of the National Academy of Sciences of the United States of America. Jul, 2012 | Pubmed ID: 22753496 Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-specific Antigen Cancer Discovery. Apr, 2012 | Pubmed ID: 22576209 Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-hairpin RNA Library Screening PloS One. 2012 | Pubmed ID: 22509301 Converting Cancer Therapies into Cures: Lessons from Infectious Diseases Cell. Mar, 2012 | Pubmed ID: 22424221 ARN-509 : Un Antiandrogène Novateur Pour Le Traitement Du Cancer De La Prostate Cancer Research. Jan, 2012 | Pubmed ID: 22266222 Aptitude Conférée Par Des Mutations De BCR-ABL Kinase Domaine Détermine Le Risque De Résistance Préexistant Dans La Leucémie Myéloïde Chronique PloS One. 2011 | Pubmed ID: 22140458 TMPRSS2-ERG Statut Dans La Circulation De Cellules Tumorales Comme Biomarqueurs Prédictifs De La Sensibilité Dans Le Cancer De La Prostate Résistant à La Castration De Patients Traités Par L'acétate D'abiratérone European Urology. Nov, 2011 | Pubmed ID: 21802835 Mesure Non Invasive De Récepteur D'androgène Signalisation Avec Un Produit Radiopharmaceutique émetteur De Positrons Cet Antigène Prostatique Spécifique Membranaire De Cibles Proceedings of the National Academy of Sciences of the United States of America. Jun, 2011 | Pubmed ID: 21606347 Règlement De Rétroaction Réciproque Du PI3K Et Androgène Récepteurs De Signalisation Dans Le Cancer De La Prostate De PTEN Déficient Cancer Cell. May, 2011 | Pubmed ID: 21575859 SAF Et Signalisation NF-κB Modulent La Dépendance à L'égard Des Cancers Du Poumon Mutant EGFR Nature. Mar, 2011 | Pubmed ID: 21430781 MYC Coopère Avec AKT Dans La Tumorigenèse La Prostate Et Modifie La Sensibilité Aux Inhibiteurs De MTOR PloS One. 2011 | Pubmed ID: 21394210 ETV1 Est Un Facteur De Survie Des Lineage Qui Coopère Avec Le KIT Dans Les Tumeurs Stromales Gastro-intestinales Nature. Oct, 2010 | Pubmed ID: 20927104 Variantes D'épissage De Récepteurs Androgènes Constitutivement Actif Exprimées En Cancer De La Prostate Résistant à La Castration Nécessitent Le Récepteur Des Androgènes Pleine Longueur Proceedings of the National Academy of Sciences of the United States of America. Sep, 2010 | Pubmed ID: 20823238 Profilage Génomique Intégrative Du Cancer De La Prostate Humain Cancer Cell. Jul, 2010 | Pubmed ID: 20579941 Régulation Transcriptionnelle Coordonnée Par ERG Et Androgène Récepteurs Dans Les Cancers De La Prostate De Fusion-positif Cancer Cell. May, 2010 | Pubmed ID: 20478521 Activité Antitumorale De MDV3100 Dans Le Cancer De La Prostate Résistant à La Castration : Une étude De Phase 1-2 Lancet. Apr, 2010 | Pubmed ID: 20398925 Relation Structure-activité Pour Les Antagonistes Des Récepteurs Aux Androgènes Thiohydantoïne Pour Cancer De La Prostate Résistant à La Castration (fonciers) Journal of Medicinal Chemistry. Apr, 2010 | Pubmed ID: 20218717 Hématopoïèse Clonale Dans Les Cellules De Moelle Osseuse Négatif Du Chromosome Philadelphie Des Patients De Leucémie Myéloïde Chronique Traités Par Dasatinib Leukemia Research. Jun, 2010 | Pubmed ID: 19804904 Leçons Tirées De L'élaboration D'inhibiteurs De La Kinase Clinical Advances in Hematology & Oncology : H&O. Sep, 2009 | Pubmed ID: 20020670 Changement De Paradigmes : Les Graines De La Dépendance De L'oncogène Nature Medicine. Oct, 2009 | Pubmed ID: 19812578 Protéasome Et Inactivation Génique De La NF1 Suppresseur De Tumeur Dans Gliomagenesis Cancer Cell. Jul, 2009 | Pubmed ID: 19573811 Trouver Et Droguer Les Vulnérabilités Des Cancers RAS-dépendants Cell. May, 2009 | Pubmed ID: 19490885 Coopérativité De TMPRSS2-ERG Avec Activation Voie Pi 3-kinase Dans L'oncogenèse La Prostate Nature Genetics. May, 2009 | Pubmed ID: 19396167 Développement D'un Antiandrogène De Deuxième Génération Pour Le Traitement Du Cancer Avancé De La Prostate Science (New York, N.Y.). May, 2009 | Pubmed ID: 19359544 Histones Déacétylases Sont Requises Pour La Fonction Des Récepteurs Aux Androgènes Dans Le Cancer De La Prostate Hormono-sensible Et Résistant à La Castration Cancer Research. Feb, 2009 | Pubmed ID: 19176386 Recherche Translationnelle : Sommes-nous Sur La Bonne Voie ? 2008 L'American Society for Clinical Investigation Discours Présidentiel The Journal of Clinical Investigation. Nov, 2008 | Pubmed ID: 18982165 La Voie Du Facteur Nucléaire-kappaB Contrôle La Progression Du Cancer De La Prostate Androgéno-indépendant De Croissance Cancer Research. Aug, 2008 | Pubmed ID: 18701501 Un Point De Contrôle Kip1 P27 De Dépendante De La Néoplasie Intra-épithéliale Prostatique Induit La Sénescence Et Inhibe La Prolifération Cellulaire Et La Progression Du Cancer Cancer Cell. Aug, 2008 | Pubmed ID: 18691549 Le Ciblage De La Voie De Récepteur D'androgène Dans Le Cancer De La Prostate Current Opinion in Pharmacology. Aug, 2008 | Pubmed ID: 18674639 Le Problème De Biomarqueurs Du Cancer Nature. Apr, 2008 | Pubmed ID: 18385728 Quelque Chose De Perdu--quelque Chose Acquise : Les ASQUES Commence Son Deuxième Siècle The Journal of Clinical Investigation. Apr, 2008 | Pubmed ID: 18382722 Activité Antitumorale De La Rapamycine Dans Une Phase J'essai Pour Les Patients Atteints D'un Glioblastome Récurrent PTEN Déficient PLoS Medicine. Jan, 2008 | Pubmed ID: 18215105 Séquentielle Thérapie Inhibiteur De Kinase ABL Sélectionne Pour Les Mutations De BCR-ABL Résistantes Aux Médicaments Composées Avec Activité Oncogénique Altérée The Journal of Clinical Investigation. Sep, 2007 | Pubmed ID: 17710227 La Phosphorylation De La Boucle De L'ATP Binding Redirige Oncogénicité De Mutants De BCR-ABL Résistantes Aux Médicaments Proceedings of the National Academy of Sciences of the United States of America. Dec, 2006 | Pubmed ID: 17164333 Biologie Du Cancer De La Prostate Progressive, Résistant à La Castration : Réalisé Des Thérapies Ciblant L'axe Signalisation Du Récepteur Des Androgènes Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2005 | Pubmed ID: 16278481 Inhibition Des Mutants Résistants Aux Médicaments Des Kinases De Récepteur ABL, KIT Et EGF Proceedings of the National Academy of Sciences of the United States of America. Aug, 2005 | Pubmed ID: 16046538 Un Inhibiteur De Pyridopyrimidine Roman De Kinase Abl Est Un Inhibiteur Picomoles De Cellules K562 Bcr-abl-conduit Et Est Efficace Contre Des Mutants Résistants STI571 Bcr-abl Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2003 | Pubmed ID: 12684394 Les cultures organoïdes de la prostate comme outils pour traduire les génotypes et les profils mutationnels en réponses pharmacologiques Kyrie J. Pappas1, Danielle Choi1, Charles L. Sawyers1,2, Wouter R. Karthaus1 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 2Howard Hughes Medical Institute JoVE 60346 Cancer Research
Les cultures organoïdes de la prostate comme outils pour traduire les génotypes et les profils mutationnels en réponses pharmacologiques Kyrie J. Pappas1, Danielle Choi1, Charles L. Sawyers1,2, Wouter R. Karthaus1 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 2Howard Hughes Medical Institute JoVE 60346 Cancer Research